Abstract: The present invention is directed to novel dipeptide thereof, represented by the general Formula I:
where R1-R3, X and Y are defined herein. The present invention also relates to the discovery that compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire organs occurs.
Type:
Grant
Filed:
April 7, 2000
Date of Patent:
March 12, 2002
Assignee:
Cytovia, Inc.
Inventors:
Sui Xiong Cai, Eckard Weber, Yan Wang, Gordon B. Mills, Douglas R. Green
Abstract: This invention is directed to a stabilized biocidal composition which comprises a mixture of at least one halopropynyl compound, and particularly a halopropynyl carbamate fungicide such as IPBC, a UV absorber and an organic epoxide.
Abstract: The present invention relates to cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives of formula I
in which A(1), A(2), A(3), R(1), R(2), R(3), R(4), X, Y, and Z have the meanings indicated in the claims. Compounds of formula I are valuable pharmaceutical active compounds which exhibit, for example, an inhibitory action on ATP-sensitive potassium channels in the cardiac muscle and/or in the cardiac nerve and are suitable, for example, for the treatment of disorders of the cardiovascular system such as coronary heart disease, arrhythmias, cardiac insufficiency or cardiomyopathies, or for the prevention of sudden cardiac death, or for improving decreased contractility of the heart. The invention furthermore relates to processes for the preparation of compounds of formula I, their use, and pharmaceutical preparations comprising them.
Type:
Grant
Filed:
May 19, 2000
Date of Patent:
February 26, 2002
Assignee:
Aventis Pharma Deutschland GmbH
Inventors:
Holger Heitsch, Heinrich Christian Englert, Klaus Wirth, Heinz Gögelein
Abstract: The present invention relates to urethanes and the thio and dithio analogues thereof of general formula
wherein
m, n, A, X, Y and R1 to R8 are defined as in claim 1, the enantiomers, diastereomers and the salts thereof, particularly the physiologically acceptable acid addition salts thereof which have valuable properties, particularly an inhibitory effect on cholesterol biosynthesis, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
Type:
Grant
Filed:
March 24, 1999
Date of Patent:
February 12, 2002
Assignee:
Boehringer Ingelheim Pharma KG
Inventors:
Roland Maier, Rudolf Hurnaus, Michael Mark, Bernhard Eisele, Peter Mueller, Gebhard Adelgoss, Gebhard Schilcher
Abstract: Compounds and methods for mitigating neurodegeneration, effecting neuroprotection and/or effecting cognition enhancement in a subject are described. Neurological or cognitive conditions are treated by administering to a subject an effective amount of a therapeutic compound comprising a nitrate ester, or a pharmaceutically acceptable salt or ester thereof.
Type:
Application
Filed:
May 10, 2001
Publication date:
February 7, 2002
Inventors:
Gregory R.J. Thatcher, Brian M. Bennett, James N. Reynolds, Roland J. Boegman, Khem Jhamandas
Abstract: Methods and compositions for preventing or treating allergic diseases of the eye, nose, skin, ear, gastrointestinal tract, airways or lung and preventing or treating manifestations of systemic mastocytosis are disclosed. The compositions contain a mast cell stabilizing disulfide derivative as an active ingredient.
Type:
Application
Filed:
April 25, 2001
Publication date:
January 31, 2002
Applicant:
Alcon Universal Ltd.
Inventors:
Mark R. Hellberg, Zixia Feng, Steven T. Miller
Abstract: A microbiocidal composition including a first component comprises a guanidine compound, a second component which comprises either prochloraz, propiconazole or iodocarb, wherein the weight ratio of first component to second component is in the range of from about 32:1 to about 1:16.
The microbiocidal composition provides effective and broader control of micro-organisms in various industrial systems and for household products, agricultural products and biomedical products.
Type:
Grant
Filed:
August 28, 2000
Date of Patent:
January 29, 2002
Inventors:
George William Mason, Peter James Hayward, Wallace J Rae, John Doyle
Abstract: Compounds characterized generally as propargyl glycine amino propargyl diol derivatives are useful for treatment of a disorder mediated by inhibiting plasma renin activity.
Abstract: The new compound, dimethy[3-(propoxycarbonylamino)propyl]ammonium O-ethylphosphonate, having fungicidal activity, its preparation, compositions comprising it and methods for its use in agriculture.
Type:
Grant
Filed:
December 12, 2000
Date of Patent:
January 15, 2002
Assignee:
Aventis CropScience UK Limited
Inventors:
Norman John De'Ath, John Klostermyer, Albert Schirring, Michael Alan Webb, Geoffrey Gower Briggs
Abstract: Novel compounds, pharmaceutical compositions and methods are disclosed for producing local anesthesia of long-duration. The compounds of this invention are multibinding compounds that comprise from 2 to 10 ligands covalently attached to a linker or linkers, each ligand being capable of binding to a ligand binding site in a voltage-gated Na+ channel to modulate the biological processes/functions thereof.
Type:
Grant
Filed:
April 2, 1999
Date of Patent:
January 8, 2002
Assignee:
Advanced Medicine, Inc.
Inventors:
Sabine M. Axt, Timothy J. Church, Witold Hruzewicz, John R. Jacobsen, Thomas E. Jenkins, Yu-Hua Ji, J. Kevin Judice
Abstract: This invention relates to an insecticidal and miticidal composition which contains as active ingredients chlorfenapyr [4-bromo-2-(chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)pyrrole-3-carbonitrile] in combination with asynergistic amount of at least one of a carbamate-type insecticidal compound.
Abstract: The present invention is directed to monomeric and polymeric compositions based upon polymeric urethane surfactants which are derived from linear, branched, or aromatic compounds of synthetic or natural origin, preferably from tertiary amines and diisocyanate compounds. The urethane polymers of the present invention may be in the form of betaines, quaternium salts, tertiary amine salts or N-oxides. The compounds of the present invention may be incorporated into personal care formulations such as cosmetics, dental care products and toiletries to improve at least one and preferably two or more characteristics of such formulations.
Type:
Grant
Filed:
March 24, 1999
Date of Patent:
November 13, 2001
Assignee:
Fleet Bank, National Association
Inventors:
Albert Zofchak, Madeline Kenney, John Obeji, Michael Mosquera
Abstract: A method for controlling fungi using a phenylhydrazine derivative compound of the formula:
wherein:
X is phenyl, phenylalkoxy, phenoxy, or benzyl, alone or in combination with one or more halogen, alkyl, or alkylthio;
Y is hydrogen, alkanoyl, haloalkanoyl, or alkoxy carbonyl; and
R is hydrogen, alkyl, haloalkyl, alkoxy, haloalkoxy, or phenylalkoxy.
Type:
Grant
Filed:
September 7, 1999
Date of Patent:
October 2, 2001
Assignees:
Uniroyal Chemical Company, Inc., Crompton Co./Cie
Inventors:
Mark Achiel Dekeyser, Kenneth Wesley Seebold, Jr., Gaik-Lean Chee
Abstract: The production of IgA is selectively inhibited by orally administering 15-deoxyspergualin or pharmacologically acceptable salts thereof, thus preventing and treating IgA-associated immunological diseases such as IgA nephropathy.
Abstract: A method of termite control consists of injecting a foam formulation above ground into the walls of a structure infested with termites or other undesirable pests. The inner spaces of affected walls are flooded at and above ground level to ensure that the foam formulation reaches all passages open to the soil under the structure and establishes an above-ground layer of pest-control chemicals. The foam penetrates all porous material exposed to the injection and impregnates it with active ingredients that remain embedded in the material long after the foam disappears, thereby retaining the insecticidal, repellant and preservative properties of the active agents for a long time without exposure to normal degrading forces. The pest-control formulation preferably comprises pesticide, repellant and preservative components, and a foaming agent in a liquid carrier.
Abstract: The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting a cell with a compound, such as a polypeptide or small molecule in an amount sufficient to control the aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity. The present invention further makes available methods and reagents for ameliorating the consequences of hedgehog loss-of-function, ptc gain-of-function, or smoothened loss-of-function comprising contacting a cell with a compound, such as a polypeptide or small molecule, in an amount sufficient to ameliorate the In certain embodiments, the subject compounds, e.g., a cAMP analog, adenylate cyclase agonist, or cAMP phosphodiesterase inhibitor, regulate cAMP levels, which in turn modulates activity of the hedgehog pathway.
Abstract: There are described a flowable composition for controlling harmful insects and representatives of the order Acarina, comprising at least one pesticidally active compound, one or more signal substances selected from the group consisting of pheromones, kairomones and attractants, a UV absorber or a UV absorber mixture and, if appropriate, one or more additives selected from the group consisting of viscosity-regulating thickeners, fillers, solvents and other formulation auxiliaries,
Type:
Application
Filed:
February 22, 2001
Publication date:
September 13, 2001
Inventors:
Dieter Hofer, Max Angst, Pierre-Joseph Charmillot
Abstract: The present invention relates to novel 2-aryl-3-hydroxy-&Dgr;2-cyclopentene-1-one derivatives of the formula (I)
in which
A, B, D1, D2, G, W, X, Y and Z are each as defined in the description,
to processes for their preparation and to their use as herbicides and pesticides.
Type:
Grant
Filed:
August 31, 1999
Date of Patent:
June 26, 2001
Inventors:
Christoph Erdelen, Ulrike Wachendorff-Neumann, Reiner Fischer, Alan Graff, Norbert Mencke, Andreas Turberg
Abstract: New active compound combinations of valinamide derivatives of the formula (I)
in which
R1 and R2 has the meaning given in the description,
with known fungicidal active substances, and their use for combating phytopathogenic fungi are described.
Type:
Grant
Filed:
April 3, 2000
Date of Patent:
June 12, 2001
Assignee:
Bayer Aktiengesellschaft
Inventors:
Heinz-Wilhelm Dehne, Wilhelm Brandes, Karl-Heinz Kuck, Thomas Seitz
Abstract: A method for combatting plant fungi in a plant, which comprises applying to the seeds or tubers of the plant, an effective amount of a fungicidal composition comprising a fungicidally effective amount of a 2-alkoxyiminoacetamide compound, optionally in admixture with one or both of an alkylene bis-dithiocarbamate complex salt and a thiophanate compound. Fungicidal compositions comprising a fungicidally effective amount of a 2-alkoxyiminoacetamide compound, an alkylene bis-dithiocarbamate complex salt, and a thiophanate compound, are also described.
Abstract: This invention is directed to a broad spectrum antimicrobial composition which comprises a mixture of an iodopropynyl compound in combination with 2-(methoxycarbonylamino)benzimidazole and, where desirable, an algicide said mixture provided in an amount sufficient to protect a substrate from attack by one or more organisms. The composition can be used broadly in industrial systems and more particularly with substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, caulking, sealants, textiles, leather, wood, preservatives, metal working fluids, drilling muds, clay slurries, glazes, optical brightness, carpet backing, pigments and as a preservative for other aqueous and wet state products, and the like.
Abstract: Compositions of cis-jasmone were found to effectively attract adult Lepidoptera. The cis-jasmone may be used alone or in combination with one or more other volatiles of the Japanese honeysuckle flower, particularly linalool and/or phenylacetaldehyde. By attracting the adult Lepidoptera to attracticidal baits and/or field traps, the attractants are useful for the control and monitoring of these agricultural pests.
Type:
Grant
Filed:
July 28, 1997
Date of Patent:
February 20, 2001
Assignee:
The United States of America as represented by the Secretary
of Agriculture
Abstract: A method of using a compound of formula (I) wherein R.sup.1, R.sup.2, R.sup.3, X and n have any of the meanings defined in the specification, to antagonize glutamate binding, or to treat glutamate-related disorders is provided. Novel compounds, intermediates and pharmaceutical compositions are also provided.
Type:
Grant
Filed:
September 13, 1999
Date of Patent:
December 5, 2000
Inventors:
Morris Faiman, John V. Schloss, Jang-Yen Wu
Abstract: This invention relates to a composition for controlling harmful fungi comprising, in a solid or liquid carrier,a) at least one carbamate of the formula I ##STR1## where X is CH or N andthe radicals R.sup.a and R.sup.b independently of one another are a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.4 -alkyl or a C.sub.1 -C.sub.4 -haloalkyl group; andb) at least one valine amide of the formula II ##STR2## where R.sup.1 is C.sub.3 -C.sub.4 -alkyl andR.sup.2 is naphthyl or phenyl, the phenyl radical being substituted in the 4-position by a halogen atom, a C.sub.1 -C.sub.4 -alkyl group or C.sub.1 -C.sub.4 -alkoxy group.
Type:
Grant
Filed:
February 22, 1999
Date of Patent:
December 5, 2000
Assignee:
BASF Aktiengesellschaft
Inventors:
Ruth Muller, Herbert Bayer, Hubert Sauter, Karl Eicken, Frank Wetterich, Eberhard Ammermann, Gisela Lorenz, Siegfried Strathmann, Maria Scherer, Klaus Schelberger, Bernd Muller, Joachim Leyendecker
Abstract: Compounds of Formula I ##STR1## are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or .alpha.-hydroxyamide group and Z is an acyl or .alpha.-ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.
Type:
Grant
Filed:
May 26, 1999
Date of Patent:
November 21, 2000
Assignee:
Pharmacopeia, Inc.
Inventors:
Carolyn DiIanni Carroll, Roland Ellwood Dolle, III, Yvonne Class Shimshock, Timothee Felix Herpin
Abstract: The present invention relates to synthetic methods for the production of both optically active and racemic 5,5-disubstituted-3,4-dihydroxy-2(5H)-furanones; 5-[(4-aryl)-3-butynyl]-3,4-dihydroxy-2(5H)-furanones; 5-(2-arylthio)ethyl-3,4-dihydroxy-2(5H)-furanones; and 5-(2-aryloxy)ethyl-3,4-dihydroxy-2(5H)-furanones. This invention further relates to the use of the above mentioned compounds as anti-inflammatory agents through their action as mixed inhibitors of lipid peroxidation, 5-lipoxygenase, cyclooxygenase-1 and cyclooxygenase-2. The invention further relates to the use of such compounds in the treatment of chronic inflammatory disorders such as asthma, rheumatoid arthritis, inflammatory bowel disease, atherosclerosis, acute respiratory distress syndrome, and central nervous system disorders such as Alzheimer's and Parkinson's disease wherein reactive oxygen species and inflammatory mediators are contributing deleterious factors.
Type:
Grant
Filed:
May 19, 1999
Date of Patent:
October 24, 2000
Assignee:
Oxis International Inc.
Inventors:
Allen T. Hopper, John A. Ziemniak, Robert E. Johnson
Abstract: Methods are provided for conducting surgical procedures in a patient wherein, during the surgical procedure, autonomous ventricular electrical conductivity and escape beats are reversibly and transiently suppressed to facilitate the surgical procedure. Also provided are compositions which are capable of inducing ventricular asystole in a patient. The compositions may include an AV node blocker. In one embodiment, compositions including an atrioventricular (AV) node blocker and a .beta.-blocker are provided, wherein the .beta.-blocker is present in an amount sufficient to substantially reduce the amount of AV node blocker required to induce ventricular asystole in the patient. The compositions and methods may be used for inducing temporary ventricular asystole in a beating heart, and to facilitate the performance of a variety of surgical techniques, including minimally invasive microsurgical techniques.
Abstract: A method for combatting plant fungi in a plant, which comprises applying to the seeds or tubers of the plant, an effective amount of a fungicidal composition comprising a fungicidally effective amount of a 2-alkoxyiminoacetamide compound, optionally in admixture with one or both of an alkylene bis-dithiocarbamate complex salt and a thiophanate compound. Fungicidal compositions comprising a fungicidally effective amount of a 2-alkoxyimino-acetamide compound, an alkylene bis-dithiocarbamate complex salt, and a thiophanate compound, are also described.
Abstract: This invention is directed to a method for stabilizing a composition which comprises a mixture of a halopropargyl compound. The composition can be used broadly in industrial systems and more particularly with substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, caulking, sealants, textiles, and the like.
Type:
Grant
Filed:
April 15, 1999
Date of Patent:
September 26, 2000
Assignee:
Troy Technology Corporation, Inc.
Inventors:
Kamlesh D. Gaglani, Eeva-Liisa Kuusisto, John Hansen, Ismael Colon
Abstract: The invention is directed to a biocidal composition for inhibition fungal, bacterial and algae growth which comprises a mixture of tetrachloroisophthalonitrile and 3-iodo-2-propynly butyl carbamate.
Abstract: Methods are provided for conducting surgical procedures in a patient wherein, during the surgical procedure, autonomous ventricular electrical conductivity and escape beats are reversibly and transiently suppressed to facilitate the surgical procedure. Also provided are compositions which are capable of inducing ventricular asystole in a patient. The compositions may include an AV node blocker. In one embodiment, compositions including an atrioventricular (AV) node blocker and a .beta.-blocker are provided, wherein the .beta.-blocker is present in an amount sufficient to substantially reduce the amount of AV node blocker required to induce ventricular asystole in the patient. The compositions and methods may be used for inducing temporary ventricular asystole in a beating heart, and to facilitate the performance of a variety of surgical techniques, including minimally invasive microsurgical techniques.
Abstract: Fish mycoses and single-cell ectoparasites on fish are controlled using an active compound suitable for inhibiting the mitochondrial respiratory chain at the stage of the b/c.sub.1 complex.
Type:
Grant
Filed:
February 17, 1998
Date of Patent:
June 13, 2000
Assignee:
BASF Aktiengesellschaft
Inventors:
Gerhard Peter Dohmen, Christoph Kunast, Reinhart Munk, Gerhard Rothhaas
Abstract: The present invention relates to fungicidal compositions and their use as a method for controlling phytopathogenic fungi comprising the application of a selected fungicidally active N-acetonylbenzamide compound and a second fungicidally active compound selected from the group consisting of an inhibitor of respiration at cytochrome complex III, ziram, fluazinam, zarilamide, chlorothalonil, propamocarb, folpet, fosetyl-aluminum or a fungitoxic metabolite thereof, a triphenyltin type fungicide and a copper containing fungicide to plant seed, to plant foliage or to a plant growth medium. The compositions and method of use provide higher fungicidal activity than separate use of the same compounds.
Type:
Grant
Filed:
November 4, 1999
Date of Patent:
June 13, 2000
Assignee:
Rohm and Haas Company
Inventors:
David Hamilton Young, Willie Joe Wilson, Anne Ritchie Egan, Enrique Luis Michelotti
Abstract: The present invention provides 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane (DAD) isosteres comprising benzamide, sulfonamide and anthranilamide subunits, a pharmaceutical composition comprising such compounds, a method of using such compounds to treat retroviral, specifically HIV and more specifically HIV-1 and HIV-2, infections in mammals, particularly humans, a method of synthesizing asymmetric DAD isosteres comprising benzamide, sulfonamide and anthranilamide subunits, and a method of using such compounds to assay new compounds for antiretroviral activity.
Type:
Grant
Filed:
March 16, 1998
Date of Patent:
May 23, 2000
Assignee:
The United States of America as represented by the Department of Health and Human Services
Abstract: The present invention relates to insecticidal mixtures of chloronicotinyl insecticides of the formula (I) ##STR1## in which R.sup.1 represents C.sub.1 -C.sub.5 -alkyl,R.sup.2 represents hydrogen or C.sub.1 -C.sub.5 -alkylorR.sup.1 and R.sup.2 together represent --CH.sub.2 --CH.sub.2 --; --CH.sub.2 --CH.sub.2 --CH.sub.2 -- or ##STR2## X represents an NH group, NCH.sub.3 group or represents sulphur, Y represents nitrogen or a CH group andZ represents cyano or nitro,with one or more of the synergists mentioned in the description.
Type:
Grant
Filed:
July 27, 1999
Date of Patent:
May 9, 2000
Assignee:
Bayer Aktiengesellschaft
Inventors:
Christoph Erdelen, Wolfgang Kramer, Kai-Uwe Bruggen
Abstract: New active compound combinations of valinamide derivatives of the formula (I) ##STR1## in which R.sup.1 and R.sup.2 has the meaning given in the description,with known fungicidal active substances, and their use for combating phytopathogenic fungi are described.
Type:
Grant
Filed:
July 6, 1998
Date of Patent:
May 2, 2000
Assignee:
Bayer Aktiengesellschaft
Inventors:
Heinz-Wilhelm Dehne, Wilhelm Brandes, Karl-Heinz Kuck, Thomas Seitz
Abstract: The present invention is concerned with diaryl compounds of formula (I) and their use in medical therapy, particularly in the prophylaxis or treatment of a clinical condition for which an ACAT inhibitor is indicated, such as hyperlipidaema or atherosclerosis. The invention also relates to pharmaceutical compositions and processes for the preparation of compounds according to the invention.
Type:
Grant
Filed:
February 5, 1998
Date of Patent:
March 28, 2000
Assignee:
Glaxo Wellcome Inc.
Inventors:
Richard James Arrowsmith, John Gordon Dann, Karl Witold Franzmann, Simon Teanby Hodgson, Peter John Wates
Abstract: Methods are provided for conducting surgical procedures in a patient wherein, during the surgical procedure, autonomous ventricular electrical conductivity and escape beats are reversibly and transiently suppressed to facilitate the surgical procedure. Also provided are compositions which are capable of inducing ventricular asystole in a patient. The compositions may include an AV node blocker. In one embodiment, compositions including an atrioventricular (AV) node blocker and a .beta.-blocker are provided, wherein the .beta.-blocker is present in an amount sufficient to substantially reduce the amount of AV node blocker required to induce ventricular asystole in the patient. The compositions and methods may be used for inducing temporary ventricular asystole in a beating heart, and to facilitate the performance of a variety of surgical techniques, including minimally invasive microsurgical techniques.
Abstract: Compounds of formula (I): ##STR1## wherein: R.sup.1 is alkyl; R.sup.2a, R.sup.2b, R.sup.2c and R.sup.2d are the same or different and each is hydrogen, optionally substituted alkyl or various other organic groups; R.sup.3 is alkyl; R.sup.4 is a group of formula (II), (III), (IV), (V), (VI), (VII), (VIII) or (IX): ##STR2## wherein: A.sup.1 is a single bond, alkylene or alkenylene; A.sup.2 is or alkenylene; A.sup.3 is a single bond, alkyleneor alkenylene; R.sup.5a and R.sup.5b are the same or different and each is hydrogen, alkyl or various other groups; R.sup.6 is alkyl or phenyl; R.sup.7 is hydrogen or alkyl; R.sup.8 is alkyl or various other groups; and n is 0 and pharmaceutically acceptable salts thereof have valuable inhibitory activity against acyl-CoA: cholesterol acyl transferase.
Abstract: The present invention provides novel dimeric cationic lipids. The present invention further provides compositions of these lipids with anionic or polyanionic macromolecules, methods for interfering with protein expression in a cell utilizing these compositions and a kit for preparing the same.
Type:
Grant
Filed:
March 6, 1997
Date of Patent:
March 7, 2000
Assignee:
Promega Biosciences, Inc.
Inventors:
David Aaron Schwartz, Brian Patrick Dwyer, William J. Daily, Kumar Srinivasan, Bob Dale Brown
Abstract: This invention provides novel cationic lipids, particularly guanidino lipids, and methods for their preparation. Also provided are polyanionic-lipid complexes comprising the lipids of the invention, their preparation and use to deliver biologically active substances, particularly nucleic acids to cells.
Type:
Grant
Filed:
October 20, 1997
Date of Patent:
March 7, 2000
Assignee:
Syntex (U.S.A.) Inc.
Inventors:
Paula N. Belloni, Donald R. Hirschfeld, John O. Link, John J. Nestor, Jr., Gary A. Peltz
Abstract: This invention is directed to a method for stabilizing a composition which comprises a mixture of a halopropargyl compound. The composition can be used broadly in industrial systems and more particularly with substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, caulking, sealants, textiles, and the like.
Type:
Grant
Filed:
June 6, 1996
Date of Patent:
January 25, 2000
Assignee:
Troy Technology Corporation, Inc.
Inventors:
Kamlesh Gaglani, Eeva-Liisa Kuusisto, John Hansen, Ismael Colon
Abstract: New microbicidal, optionally solvent- and emulsifier-free microbicidal active compound combinations and agents comprising known azole fungicides and quaternary ammonium compounds and their use in the preservation of materials.
Type:
Grant
Filed:
April 4, 1995
Date of Patent:
November 23, 1999
Assignee:
Bayer Aktiengesellschaft
Inventors:
Georg-Wilhelm Ludwig, Otto Exner, Karl-Heinz Buchel, Graham Holmwood
Abstract: Novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates and processes for the preparation thereof, and methods of reducing inflammation and cell proliferation, and relieving memory dysfunction, and inhibiting bacterial and fungal growth are disclosed.
Type:
Grant
Filed:
April 24, 1996
Date of Patent:
November 2, 1999
Assignee:
Hoechst Marion Roussel
Inventors:
John Joseph Tegeler, Barbara Seavey Rauckman, Russell Richard Lee Hamer, Brian Scott Freed, Gregory Harold Merriman
Abstract: The invention relates to a hair revitalizing tonic composition containing, as an active ingredient, at least one lipid derivative of the general formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and Y are as defined in the specification, and a and b are 0 or 1, as well as its use. Thus, there is provided a hair revitalizing tonic composition having an excellent hair loss prevention and hair revitalizing effect and, moreover, an excellent dandruff and itchy scalp prevention effect.
Type:
Grant
Filed:
June 3, 1997
Date of Patent:
October 26, 1999
Assignees:
Shiseido Company, Ltd., Takeda Chemical Industries, Ltd.
Abstract: The present invention relates to a dimeric urethane compounds derived from monohydric alcohols, generally fatty alcohols, and a diisocyanate according to the following reaction scheme: ##STR1## wherein R.sub.1 is selected from the group of saturated or halogen substituted linear, cyclic or branch-chained hydrocarbons and R.sub.2 is a linear, cyclic or branch-chained alkyl or aminoalkyl group ranging from two to 200 carbon atoms, preferably two to 50 carbons, more preferably 6 to 36 carbons, said urethane compound being substantially free from terminal hydroxyl groups.
Type:
Grant
Filed:
January 24, 1997
Date of Patent:
October 26, 1999
Assignee:
Alzo, Inco.
Inventors:
Albert Zofchak, Madeline Kenney, John Obeji, Michael Mosquera
Abstract: Improved liquid antimicrobial solutions useful as preservative additives to personal care preparations, particularly cosmetic formulations and the like, are provided which comprise 1,3-dimethylol-5,5-disubstituted hydantoin, liquid aromatic alcohol, and iodoalkynyl alkyl carbamate. A preferred antimicrobial solution can be prepared by producing the 1,3,dimethylol-5,5-disubstituted hydantoin in situ in the selected liquid aromatic alcohol and then adding to the resulting solution the previously prepared iodoalkynyl alkyl carbamate. The solutions are surprisingly water dispersible and display broad spectrum antimicrobial effectiveness, particularly antifungal effectiveness, at a relatively low usage concentration in a cosmetic medium.
Type:
Grant
Filed:
March 30, 1998
Date of Patent:
October 12, 1999
Assignee:
McIntyre Group, Ltd.
Inventors:
Thomas G. Schoenberg, Richard J. Otterson, Dennis Abbeduto
Abstract: This invention is directed to a broad spectrum fungicide/algaecide composition which comprises a mixture of (a) at least one halopropynyl compound and (b) at least one sulfur-containing s-triazine, said mixture provided in an amount to prevent and/or protect a substrate from attack by one or more fungal and/or algael organisms. The composition can be used broadly in industrial systems and more particularly with substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, caulking, sealants, textiles, and the like.